# Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-practice-with-anti-dementia-drugs-a-revised-third-consensus-statement/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John T. O’Brien,Clive Holmes,Matthew S. Jones,Roy Jones,Gill Livingston,Ian G. McKeith,Peter Mittler,Peter Passmore,Craig Ritchie,Louise Robinson,Elizabeth L Sampson,John‐Paul Taylor,Alan Thomas,Alistair Burns |
| Citations | 355 |
| DOI | 10.1177/0269881116680924 |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | green |
| OA URL | https://eprints.soton.ac.uk/408021/1/BAP_Guidelines_AntiDementia.pdf |
| OpenAlex ID | https://openalex.org/W2090156874 |
| PMID | 28103749 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Roy Jones](https://scholariq.org/researchers/roy-jones/)

## Paper journal

- [Journal of Psychopharmacology](https://scholariq.org/journals/journal-of-psychopharmacology/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.